July 11, 2025
  • Facebook
  • Twitter
  • LinkedIn

BiomolBiomed Viewpoints

Science in plain words

  • Home
  • News
  • About
    • BiomolBiomed Viewpoints
    • BiomolBiomed Journal
  • Journal Website
  • Reviews
  • pathology
  • microbiology
  • immunology
  • translational medicine
  • genetics
  • biochemistry
  • anatomy
  • molecular biology
  • clinical medicine
  • new methods
  • new medical entities
Latest posts
  • [ July 11, 2025 ] New Hope Against MRSA: A Promising Antibiotic Combination Author Summary
  • [ July 10, 2025 ] The Reviewer of the Month for July 2025: Zdenko Sonicki, MD, PhD Reviewer of the Month
  • [ July 9, 2025 ] DPP4 Gene Variant Linked to Fatty Liver Risk in Heart Disease Patients Author Summary
  • [ July 7, 2025 ] Pleiotropic Genes Connecting Obesity and Diabetic Microvascular Complications Author Summary
  • [ July 4, 2025 ] Anti-Müllerian Hormone’s Role in PCOS: A New Target for Treatment Author Summary
HomePD-L1

PD-L1

Thyroid Dysfunction May Predict Better Response to Lung Cancer Immunotherapy
Author Summary

Thyroid Dysfunction May Predict Better Response to Lung Cancer Immunotherapy

June 20, 2025 0

New study links immune-related thyroid issues to improved outcomes in patients with advanced non-small cell lung cancer. Non-Small Cell Lung Cancer: An Ongoing Challenge Non-small cell lung cancer (NSCLC) represents approximately 85% of all lung […]

Microsatellite instability status predicts response to anti-PD-L1 therapy regardless the histotype
News

Microsatellite instability status predicts response to anti-PD-L1 therapy regardless the histotype

July 22, 2017 0

Le et al. recently reported (Science 10.1126/science.aan6733 (2017); (ClinicalTrials.gov number, NCT01876511) on the success of immune checkpoint blockade with anti-PD-1 antibodies in the patients whose cancers exhibited microsatellite instability-high (MSI-H) status. The study included 12 […]

Recent advances in cancer immunotherapy based in immune checkpoint inhibitors
News

Recent advances in cancer immunotherapy based in immune checkpoint inhibitors

June 9, 2017 0

Targeted therapy based on the immune checkpoint inhibitors (Anti-PD1/PD-L1) has revolutionized cancer treatment and outcome of several solid and hematologic malignancies, including non-small cell lung carcinoma (NSCLC), metastatic renal cell carcinoma, metastatic malignant melanoma, advanced/metastatic […]

BiomolBiomed journal metrics

  • Impact Factor 2024 (JCR®): 2.2
  • CiteScore 2024 (Scopus): 5.2
  • Google Scholar Citations
  • Dimensions metrics

See more here…

BiomolBiomed Newsletters

Subscribe to receive the latest content and news from Biomolecules and Biomedicine. Choose from our sections or themes of your interest.

Categories

  • Author Summary
  • Conferences
  • Interview
  • News
  • Opinion
  • Reviewer of the Month
  • Topics
  • Video Summary

Archives

TELL US

What matters the most when choosing the journal to submit your article?
Vote
Follow us on Facebook

Copyright (c) 2021 Association of Basic Medical Sciences of FBIH

 

Loading Comments...